D.E. Shaw & Co
BRLI

D.E. Shaw & Co’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

D.E. Shaw & Co’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-273,638
Closed -$11.3M – 4090
2015
Q2 		$11.3M Buy
273,638
+37,598
+16% +$1.35M 0.02% 952
2015
Q1 		$8.32M Sell
236,040
-27,927
-11% -$945K 0.01% 1071
2014
Q4 		$8.48M Buy
263,967
+73,597
+39% +$2.13M 0.01% 1213
2014
Q3 		$5.34M Buy
190,370
+63,667
+50% +$1.94M 0.01% 1522
2014
Q2 		$3.83M Buy
126,703
+43,729
+53% +$1.21M 0.01% 1810
2014
Q1 		$2.3M Buy
82,974
+43,676
+111% +$1.14M ﹤0.01% 2249
2013
Q4 		$1M Buy
+39,298
New +$1.21M ﹤0.01% 3161

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

D.E. Shaw & Co's BRLI Position: Q3 2015 in Review

D.E. Shaw & Co sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 273,638 shares — an estimated $11.3M sold.

D.E. Shaw & Co first reported a position in BRLI in Q4 2013 and held it in 7 quarters. The position peaked at $11.3M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • D.E. Shaw & Co reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 273,638 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $11.3M.
  • D.E. Shaw & Co first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 7 quarters.
  • D.E. Shaw & Co's BIO-REFERENCE LABS INC-NEW- position peaked at $11.3M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on D.E. Shaw & Co's 13F filing for Q3 2015, filed 16 Nov 2015.